Clinical significance of the atrial fibrillation threshold in patients with paroxysmal atrial fibrillation

PACE - Pacing and Clinical Electrophysiology

Volumn 24, Issue 5, 2001, Pages 796-805

  Inoue, Keiji ^a   Shirayama, Takeshi ^a   Shiraishi, Hirokazu ^a   Matoba, Yayoi ^a   Imai, Hiroto ^a   Inoue, Daisuke ^a   Nakagawa, Masao ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation threshold; Diagnostic accuracy

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART CONTRACTION; HEART ELECTROPHYSIOLOGY; HEART STIMULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; SENSITIVITY AND SPECIFICITY;

EID: 0035003859     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2001.00796.x     Document Type: Article

References (37)

1. 1. Ostrander LD Jr, Brandt RL, Kjelsberg MO, et al. Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan. Circulation 1965; 31:888-898.
2. 2. Kannel WB, Abbott RD, Savage DD, et al. Coronary heart disease and atrial fibrillation: The Framingham Study. Am Heart J 1983; 106:389-396.
3. 3. Wolf PA, Kannel WB, McGee DL, et al. Duration of atrial fibrillation and imminence of stroke: The Framingham study. Stroke 1983; 14:664-667.
4. 4. Petersen P. Thromboembolic complications of atrial fibrillation and their prevention: A review. Am J Cardiol 1990; 65:24C-28C.
5. 5. Van Gelder IC, Crijns HJGM, Blanksma PK, et al. Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease. Am J Cardiol 1993; 72:560-566.
6. 6. Kannel WB, Abbott RD, Savage DD, et al. Epidemiologic features of chronic atrial fibrillation. The Framingham study. N Engl J Med 1982; 306:1018-1022.
7. 7. Cosio FG, Palacios J, Vidal JM, et al. Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: A possible manifestation of the background for reentry. Am J Cardiol 1983; 51:122-130.
8. 8. Shimizu A, Fukatani M, Tanigawa M, et al. Intra-atrial conduction delay and fragmented atrial activity in patients with paroxysmal atrial fibrillation. Jpn Circ J 1989; 53:1023-1030.
9. 9. Wyndham CRC, Amat-y-Leon F, Wu D, et al. Effects of cycle length on atrial vulnerability. Circulation 1977; 55:260-267.
10. 10. Engel TR, Luck JC, Leddy CL, et al. Diagnostic implications of atrial vulnerability. PACE 1979; 2:208-214.
11. 11. Ohe T, Matsuhisa M, Kamakura S, et al. Relation between the widening of the fragmented atrial activity zone and atrial fibrillation. Am J Cardiol 1983; 52:1219-1222.
12. 12. Ishibashi K, Inoue D, Sakai R, et al. Effects of disopyramide on the atrial fibrillation threshold in the human atrium. Int J Cardiol 1995; 52:177-184.
13. 13. Moe GK, Rheinbolt WC, Abildskov JA. A computer model of atrial fibrillation. Am Heart J 1964; 67:200-220.
14. 14. Allessie MA, Lammers WJEP, Smeets JRLM. Total mapping of atrial excitation during acetylcholine induced atrial flutter and fibrillation in the isolated canine heart. In HE Kulbertus, et al. (eds.): Atrial fibrillation. Mölndal, Sweden, AB Hässell, 1982, pp. 44-62.
15. 15. Wiener N, Rosenblueth A. The mathematical formulation of the problem of conduction of impulses in a network of connective excitable elements, specifically in cardiac muscle. Arch Inst Cardiol Mex 1946; 16:205-265.
16. 16. Graux P, Carlioz R, Rivat P, et al. Wavelength and atrial vulnerability: An endocavitary approach in humans. PACE 1998; 21:202-208.
17. 17. Luck JC, Engel TR. Dispersion of atrial refractoriness in patients with sinus node dysfunction. Circulation 1979; 60:404-412.
18. 18. Michelucci A, Padeletti L, Fradella GA. Atrial refractoriness and spontaneous or induced atrial fibrillation. Acta Cardiol 1982; 37:333-344.
19. 19. Simpson RJJ, Amara I, Foster JR, et al. Thresholds, refractory periods, and conduction times of the normal and diseased human atrium. Am Heart J 1988; 116:1080-1090.
20. 20. Tanigawa M, Fukatani M, Konoe A, et al. Prolonged and fractionated right atrial electrograms during sinus rhythm in patients with paroxysmal atrial fibrillation and sick sinus node syndrome. J Am Coll Cardiol 1991; 17:403-408.
21. 21. Cosio FG, Llovet A, Vidal JM. Mechanism and clinical significance of atrial repetitive responses in man. PACE 1983; 6:53-59.
22. 22. Pop T, Treese N, Kang JC, et al. Effect of intravenous flecainide on atrial vulnerability in man. Klin Wochenschr 1983; 61:609-615.
23. 23. Moore EN, Spear JF. Ventricular fibrillation threshold: Its physiological and pharmacological importance. Arch Intern Med 1975; 135:446-453.
24. 24. Wiggers CJ, Wégria R. Ventricular fibrillation due to single, localized induction and condenser shocks applied during the vulnerable phase of ventricular systole. Am J Physiol 1940; 128:500-505.
25. 25. Han J. Ventricular vulnerability during acute coronary occlusion. Am J Cardiol 1969; 24:857-864.
26. 26. Harumi K, Tsutsumi T, Sato T, et al. Classification of antiarrhythmic drugs based on ventricular fibrillation threshold. Am J Cardiol 1989; 64:10J-14J.
27. 27. Murakawa Y, Toda I, Nozaki A, et al. Effects of antiarrhythmic drugs on the repetitive extrasystole threshold and the ventricular fibrillation threshold. Cardiology 1989; 76:58-66.
28. 28. Kostis JB, Goodking MJ, Gotzoyannis S, et al. Effect of lidocaine on the atrial fibrillation threshold. Am Heart J 1977; 94:764-768.
29. 29. Gold RL, Bren GB, Katz RJ, et al. Independent and interactive effects of digoxin and quinidine on the atrial fibrillation threshold in dogs. J Am Coll Cardiol 1985; 6:119-123.
30. 30. Inoue M, Inoue D, Ishibashi K, et al. Effects of E-4031 on atrial fibrillation threshold in guinea pig atria: Comparative study with class I antiarrhythmic drugs. J Cardiovasc Pharmacol 1994; 24:534-541.
31. 31. Sugimoto T, Schaal SF, Wallace AG. Factors determining vulnerability to ventricular fibrillation induced by 60cps alternating current. Circ Res 1967; 21:601-608.
32. 32. Zimmermann M, Adamec R, Metzger J. Atrial vulnerability in patients with paroxysmal "lone" atrial fibrillation. PACE 1998; 21:1949-1958.
33. 33. Brignole M, Menozzi C, Sartore B, et al. The use of atrial pacing to induce atrial fibrillation and flutter. Int J Cardiol 1986; 12:45-54.
34. 34. Friedman HS, Sinha B, Tun A, et al. Zones of atrial vulnerability. Relationships to basic cycle length. Circulation 1996; 94: 1456-1464.
35. 35. Diker E, Ozdemir M, Aydogdu S, et al. Dispersion of repolarization in paroxysmal atrial fibrillation. Int J Cardiol 1998; 63:281-286.
36. 36. Pop T, Fleischmann D, Effert S. The vulnerability of the human atrium. I. Correlations between vulnerability, sinus node recovery time and intraatrial conduction time. Klin Wochenschr 1976; 54:835-838.
37. 37. Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al. Atrial fibrillation begets atrial fibrillation: A study in awake chronically instrumented goats. Circulation 1995; 92:1954-1968.